Annual Accounts Payable
$646.80 K
-$504.40 K-43.82%
December 31, 2023
Summary
- As of February 7, 2025, IKT annual accounts payable is $646.80 thousand, with the most recent change of -$504.40 thousand (-43.82%) on December 31, 2023.
- During the last 3 years, IKT annual accounts payable has fallen by -$1.07 million (-62.41%).
- IKT annual accounts payable is now -62.41% below its all-time high of $1.72 million, reached on December 31, 2020.
Performance
IKT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.53 M
+$1.19 M+88.68%
September 30, 2024
Summary
- As of February 7, 2025, IKT quarterly accounts payable is $2.53 million, with the most recent change of +$1.19 million (+88.68%) on September 30, 2024.
- Over the past year, IKT quarterly accounts payable has increased by +$1.19 million (+88.68%).
- IKT quarterly accounts payable is now -23.51% below its all-time high of $3.31 million, reached on September 30, 2020.
Performance
IKT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IKT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.8% | +88.7% |
| 3 y3 years | -62.4% | +163.7% |
| 5 y5 years | -32.2% | +163.7% |
IKT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.8% | at low | at high | +291.0% |
| 5 y | 5-year | -62.4% | at low | -23.5% | +356.7% |
| alltime | all time | -62.4% | at low | -23.5% | +356.7% |
Inhibikase Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.53 M(+88.7%) |
| Jun 2024 | - | $1.34 M(+3.6%) |
| Mar 2024 | - | $1.29 M(+100.0%) |
| Dec 2023 | $646.80 K(-43.8%) | $646.80 K(-12.0%) |
| Sep 2023 | - | $734.60 K(-2.6%) |
| Jun 2023 | - | $754.10 K(-21.4%) |
| Mar 2023 | - | $959.10 K(-16.7%) |
| Dec 2022 | $1.15 M | $1.15 M(+47.4%) |
| Sep 2022 | - | $781.20 K(-9.2%) |
| Jun 2022 | - | $860.40 K(+6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $806.20 K(-26.0%) |
| Dec 2021 | $1.09 M(-36.7%) | $1.09 M(+96.8%) |
| Sep 2021 | - | $553.80 K(-38.3%) |
| Jun 2021 | - | $897.20 K(+25.5%) |
| Mar 2021 | - | $715.00 K(-58.4%) |
| Dec 2020 | $1.72 M(+71.8%) | $1.72 M(-48.0%) |
| Sep 2020 | - | $3.31 M(+202.2%) |
| Jun 2020 | - | $1.09 M(+45.2%) |
| Mar 2020 | - | $753.50 K(-24.8%) |
| Dec 2019 | $1.00 M(+5.0%) | $1.00 M |
| Dec 2018 | $954.20 K | - |
FAQ
- What is Inhibikase Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual accounts payable year-on-year change?
- What is Inhibikase Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly accounts payable year-on-year change?
What is Inhibikase Therapeutics annual accounts payable?
The current annual accounts payable of IKT is $646.80 K
What is the all time high annual accounts payable for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual accounts payable is $1.72 M
What is Inhibikase Therapeutics annual accounts payable year-on-year change?
Over the past year, IKT annual accounts payable has changed by -$504.40 K (-43.82%)
What is Inhibikase Therapeutics quarterly accounts payable?
The current quarterly accounts payable of IKT is $2.53 M
What is the all time high quarterly accounts payable for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly accounts payable is $3.31 M
What is Inhibikase Therapeutics quarterly accounts payable year-on-year change?
Over the past year, IKT quarterly accounts payable has changed by +$1.19 M (+88.68%)